Market Currents
Shares of NuVasive (NUVA -0.9%) aren't getting much help today from upgrade to Outperform at...
-
Thursday, June 21, 2012, 12:26 PM ETShares of NuVasive (NUVA -0.9%) aren't getting much help today from upgrade to Outperform at Wells Fargo as the stock struggles to break through key technical resistance levels. Wells cites improvements in the spine market and the company's conservative 2012 guidance for the upgrade. The firm alos raised its price target range to $29 - $31 from $17 - $18.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
